David Mayer

Co-founder & Executive Chairman, Wellspent™. Building the infrastructure for employer-supported everyday wellness.

📍 Greater Boston, United States🔄 Updated September 2026💼 2 investments📅 11 years investing🗓 Last invested Feb 2016𝕏 @upgrade_to_unlock
VC🌍 United States
2
Total investments
2
Early stage
0
Mid stage
0
Late stage
11y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Feb 2016
We’re AYR. We make old soul clothes for a new era. Our denim is made in LA. Our brand was raised in NY. We obsess over fit and fabric. Quality over quantity. Longevity over trends. Were all about the joy of getting dressed, and we believe that simple, well-made clothes can make the dance even more delightful. AYR stands for All Year Round (so do we) and it’s pronounced like “fresh air.” So glad you found us. www.AYR.com
Private Investor
Apr 2015
Founded in 2014, Purple Carrot is a plant-based meal delivery service on a mission to empower you to eat more plants. We’re making it easy to cook innovative, delicious, plant-based meals to power your day.
Experience · 7 entries
All (7)
Investments (2)
Founder (2)
2024
Wellybucks, Inc.
Founder & CEO
Sep 2024
2018
Merryfield, PBC
Founder & CEO
Mar 2018
2016
Private Investor
Feb 2016
We’re AYR. We make old soul clothes for a new era. Our denim is made in LA. Our brand was raised in NY. We obsess over fit and fabric. Quality over quantity. Longevity over trends. Were all about the joy of getting dressed, and we believe that simple, well-made clothes can make the dance even more delightful. AYR stands for All Year Round (so do we) and it’s pronounced like “fresh air.” So glad you found us. www.AYR.com
2015
Private Investor
Apr 2015
Founded in 2014, Purple Carrot is a plant-based meal delivery service on a mission to empower you to eat more plants. We’re making it easy to cook innovative, delicious, plant-based meals to power your day.
2008
Partner
2008
Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 175 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.
Show all 7 entries ↓